Identification and purification of human induced pluripotent stem cell-derived atrial-like cardiomyocytes based on sarcolipin expression.
The use of human stem cell-derived cardiomyocytes to study atrial biology and disease has been restricted by the lack of a reliable method for stem cell-derived atrial cell labeling and purification. The goal of this study was to generate an atrial-specific reporter construct to identify and purify...
Main Authors: | Rebecca Josowitz, Jia Lu, Christine Falce, Sunita L D'Souza, Meng Wu, Ninette Cohen, Nicole C Dubois, Yong Zhao, Eric A Sobie, Glenn I Fishman, Bruce D Gelb |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4092021?pdf=render |
Similar Items
-
Autonomous and Non-autonomous Defects Underlie Hypertrophic Cardiomyopathy in BRAF-Mutant hiPSC-Derived Cardiomyocytes
by: Rebecca Josowitz, et al.
Published: (2016-09-01) -
Human Engineered Cardiac Tissues Created Using Induced Pluripotent Stem Cells Reveal Functional Characteristics of BRAF-Mediated Hypertrophic Cardiomyopathy.
by: Timothy J Cashman, et al.
Published: (2016-01-01) -
Are atrial human pluripotent stem cell-derived cardiomyocytes ready to identify drugs that beat atrial fibrillation?
by: Torsten Christ, et al.
Published: (2021-03-01) -
The Role of Sarcolipin in Calcium Handling and Obesity
by: Bombardier, Eric
Published: (2010) -
Sarcolipin Makes Heat, but Is It Adaptive Thermogenesis?
by: Kevin L. Campbell, et al.
Published: (2018-06-01)